Editorial Board

Dr. Pathak received his PhD in Radiation Biology from Kalyani University (Kalyani, West Bengal, India). He served as Assistant Professor in the Radiobiology Department of Manipal University (Manipal, Mangalore, Karnataka, India). He received postdoctoral training at the Armed Forces Radiobiology Research Institute (Bethesda, MD, USA). Dr. Pathak was a Research Instructor of Pharmaceutical Sciences at the University of Arkansas for Medical Sciences (UAMS), faculty member of the Division of Radiation Health in the College of Pharmacy. Dr. Pathak’s research was focused on low- and high-LET radiation induced cytogenetic alterations in mammalian cells and understanding the molecular mechanisms of cell death during his PhD He worked in the field of radiation bio-dosimetry and radiation countermeasure during his post-doctoral training. His current research interest is radiation-induced normal tissue injury particularly radiation-induced endothelial dysfunction and genomic instability using FISH-based molecular techniques. He has extensive training and practical experience working with transgenic mouse models. His one of the major research goals is to develop radiation countermeasures that can be used in the event of accidental or incidental radiation mass casualty and find out the molecular basis of radiation protection.

 Radiation, pharmaceuticals, cancer, medical sciences

Q. Quentin Li is a research scientist at the National Cancer Institute, National Institutes of Health, and was an assistant professor at the Mary Babb Randolph Cancer Center, West Virginia University Robert C. Byrd Health Sciences Center. He was a guest professor/visiting professor for six reputed universities in China. He obtained an M.D. from China and worked as dermatologist at Sun Yat-Sen University School of Medicine. He also received his M.S. in Microbiology & Immunology and Ph.D. in Pharmacology and Experimental Therapeutics from the University of Maryland School of Medicine, with postdoctoral training in Molecular and Cell Biology of Cancer in Medical Oncology Branch (formerly Medicine Branch) of the Center for Cancer Research at the National Cancer Institute. He is a member of the American Association for Cancer Research. He served as principal investigator on several grants funded by the National Institutes of Health and a pharmaceutical company. He was elected to Who’s Who in Medicine and Healthcare, Who’s Who in Science and Engineering, Who’s Who in America, and Who’s Who in the World in 2002 and 2003. He serves on the Editorial Board of 25 journals and is a reviewer for 55 scientific journals and a research & development foundation. He has authored over 100 peer-reviewed research articles and reviews and presented more than 60 papers at national and international scientific meetings

Photoimmunotherapy of cancer; Microorganisms & cancer; Cancer immunology; Chemokines & cancer; Immunopharmacology & Oncopharmacology; Molecular & cell biology of cancer; Cancer chemotherapy; New drug research & development; Natural products as anticancer agents; Apoptosis & cell cycle control in cancer; DNA damage repair & platinum drug resistance in carcinomas; Epigenetic modulation of DNA damage responses and DNA repair; Identification of biomarkers and epigenetic markers for diagnosis and treatment of carcinomas; Epigenetic regulation of gene expression in T cells and leukemic cells; Platinum and taxol drug resistance in lung cancer, ovarian cancer, bladder cancer, and other types of solid tumor.

Biography Dr. Zhang received her Ph.D. in North Dakota State University in US in 2015 and B.S. in Shenyang Pharmaceutical University in China in 2010. She continued her postdoctoral research in immuno-oncology at National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) since 2015. Her research activities focus on the epigenetic mechanisms of anti-cancer drug resistance and response in prostate cancer and colon cancer; whole genome-wide epigenetic modifications in mastocytosis disease and related clonal mast cell disorders; and novel forensic identification method of metabolites of major alkaloids of aconitum. Dr. Zhang has published multiple articles on top-ranked international peer-review journals, such as Gastroenterology, Cell Death and Disease and Molecular Cancer Therapy. She has authored nearly 20 peer-reviewed and under-reviewed research articles and served as an editor/ reviewer for over 20 medical research journals and committees.

Epigenetic Mechanisms Regulating Cancer Growth and Apoptosis, focuses on the epigenetic action and regulation by novel oncogenes, tumor suppressor genes, and tumor-suppressing microRNAs.

Targeting the Epigenetic Mechanisms for Cancer Therapy to improve the therapeutic efficacy of chemotherapy and develop new strategies to track down and eliminate cancer metastasis.

Identifying Whole Genome-Wide Epigenetic Modifications to distinguish the subvariety of mastocytosis to guide the individual precision treatment of mastocytosis and related clonal mast cell disorders.

Dr. A. Heidari, Ph.D., D.Sc. is a Postdoctoral Research Fellow in Chemistry. He has got his Ph.D. and D.Sc. degrees form California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management and also in Nanochemistry and Molecular Structure Theory. His research interests are Biophysical Chemistry, Nanochemistry, Quantum Chemistry, Biomolecular and Vibrational Spectroscopy, Molecular Modeling and Structure, Theoretical, Computational and Mathematical Chemistry, Ab initio and Density Functional Methods. He has participated at more than fifty reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Index (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Netherlands, Russia, France, Swiss, Germany, Sweden, Spain, Portugal, South Korea, China, etc. as research fellow, sabbatical and volunteer researcher or visitor heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than ten books in Chemistry. Syne, he has been awarded more than two hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals. Hitherward, he is a member of more than one hundred reputed international academic–scientific–research institutes around the world.

Biophysical Chemistry, Biomolecular Spectroscopy , Quantum Chemistry, Nanochemistry ,Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure.

M.D. from Novgorod State University (NovSU), Russia

Internship in immunology and infectious diseases (NovSU), Russia

Assistant professor in immunology (NovSU), Russia

Research Associate in Mario Negri Sud Institute for Pharmacological Research, Italy

Ph.D. in molecular biology from Wuerzburg University, Germany

Researcher in Wuerzburg University Hospital (department of Anesthesia and critical Care), Germany

Sergey Shityakov is a researcher in the Department of Anesthesia and Critical Care at Wuerzburg Hospital University. He received an M.D. in immunology and infectious diseases from Novgorod State University School of Medicine in Russia, and a Ph.D. in molecular biology from Wuerzburg University in Germany. His research interests include blood-brain barrier research, molecular docking, and molecular dynamics simulation of different biological systems, such as brain transporter proteins and carbon nanostructures. His work in these areas has been published in various peer-reviewed journals and presented at scientific conferences.

Professor Rafik Karaman is currently a distinguished professor of pharmaceutical sciences, College of Pharmacy, Al-Quds University, Jerusalem, Palestine. He received his Ph.D. degree in pharmaceutical/bioorganic chemistry from the Hebrew University in 1987, his MS degree in Pharmaceutical Sciences from the Hebrew University in 1983, and his bachelor’s degree in Pharmacy from the Hebrew University in 1981. He was an Assistant Professor at the University of Toledo and University of California at Santa Barbara for 5 years where he worked with Professor T.C.Bruice in the bioorganic chemistry field. Professor Karaman is broadly interested in the design and synthesis of prodrug systems to be used for the delivery of certain drugs that have poor water solubility or/and have low bioavailability as well as synthesis of prodrugs for masking the bitter sensation of commonly used drugs. The prodrug design is executed using ab initio, DFT, semiempirical, molecular mechanics as well as molecular dynamics and conformational dynamics methods. The overarching goal of Karaman’s research activities is to establish a method for obtaining prodrugs that their interconversion rates will be controlled or programmed by the chemical features of the linker (promoiety) attached to their active parent drugs. Professor Karaman has more than 150 peer-reviewed manuscripts and book chapters; 100 of them were published in the recent 7 years. He is currently an editor and an editorial board

1.The design of these prodrugs will be executed using DFT, Ab initio and molecular mechanics methods.

2. Design, synthesis, characterization and in vitro and in vivo kinetics of pro-prodrug systems to be used for the delivery for certain drugs that have poor water solubility or/and have low bioavailability using ab initio, DFT, semiempirical, molecular mechanics as well as molecular dynamics and conformational dynamics methods. The in-vitro studies will be conducted in media mimics that of stomach (pH 1.2), intestine (pH 6.8) and blood circulation (pH 7.4). The in-vivo studies will be conducted in certain animals and the pharmacokinetic parameters will be determined using advanced technology such as, HPLC and LC-MS. 4

3. Design and synthesis of linkers to be used for masking bitter taste of drugs that contain a hydroxyl or amine groups (antimalarial, anti-hypertension, anti-bleeding, antibacterial and anticancer drugs) using DFT calculation methods. The synthesis will be carried out using standard organic methods and the kinetic rates of the intramolecular processes will be determined by HPLC monitoring.

4. Design and synthesis of bitter taste antagonists for inactivation of the bitter taste receptor 14.The design will be accomplished using molecular orbital and molecular mechanics methods.

5. Pharmaceuticals removal from wastewater using clay micelle complex, hollow fiber, spiral wounds, charcoal and other adsorbents.

6. Pharmaceuticals removal from wastewater using photodegradation methods such as light/TiO2.

7. Stability of Pharmaceuticals in wastewater and isolation and characterization of degradation products (metabolites).

Pursuing Ph.D. Degree in Pharmaceutical Science, School of Pharmacy & Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, U.S. (2011-present) • Master’s Degree in Pharmaceutical Science, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China (2008-2011) • Bachelor’s Degree in Pharmaceutical Science, School of Pharmacy, East China University of Science and Technology, Shanghai, China (2004-2008)

Long-acting injectable and oral formulation design: nanocrystals, micelles, liposomes, polymer-drug conjugates, solid-lipid nanoparticles and microspheres • Formulation characterization techniques: particle size, charge, loading, stability, morphology, viscosity, surface tension and protein binding • Lyophilization process development and optimization • Skill of pharmaceutical applications of different stabilizers and excipients • Nanoformulation subcellular trafficking and proteomics analysis • Basic GMP/GLP knowledge

Dr.Yaowas born and grew in Hebei, P. R. China beforehe entered auniversity. In2000，he began to accept higher education majoringin pharmacy at Shandong University and obtained hisbachelor degree in 2004. Then he went into Professor Ying Zhong’s lab at Shandong Academy of Medical Sciences to pursue his master degree. After he completed his dissertation hegot his MS degree in medicinal chemistry in 2007. In the same year, he moved to Tianjin and worked in both Professor Shende Jiang’s lab at Tianjin University and Professor Hongquan Duan’s lab at Tianjin Medical University as a joint PhD student. In 2010, he successfully gained his PhD degree in applied chemistry. Then he moved south to Jiangsu and worked at School of Pharmacy, Xuzhou Medical College as a lecturer of natural products chemistry. In 2014, he was promoted as an associate professor. At the same time, he was appointed as a joint postdoctoral fellow in medicinal chemistry at University of Macau. His research interests were focused on the chemistry and biology of natural products which covers natural products chemistry, medicinal chemistry and chemical biology, including isolation, structure elucidation and biological evaluation of bioactive natural products from nature, natural products-based drug design and synthesis targeting biochemical pathways and signal transduction, biosynthesis and biotransformation of natural products, small molecular probes derived from natural products, interactions between small molecules and biomacromolecules. At present, he is a member of Chinese Chemical Society and serves as an editorial board member for Peertechz Journal of Medicinal Chemistry and Research and a peer reviewer for more than 10 academic journals. He has published more than 20 papers as a co-author and gets a NSFC grant as the PI.

Natural Products Chemistry 

Medicinal Chemistry 

Chemical Biology

Mr. Sachin Thakkar is currently a final year graduate student at the University of Texas at Austin, Texas, USA. He is currently working on a novel freezing technology to prepare dry powder vaccines using aluminum salt as an adjuvant, to overcome its long lasting problem of aggregating upon freezing. He is also working on the mucosal delivery these powder vaccines to enable needle free immunization. Additionally, he is also working on understanding the mechanisms of the better adjuvant activity of the aluminum nanoparticles, and microneedle based transdermal nanoparticulate vaccine delivery systems. His research article was chosen as a cover story by the Journal of Controlled Release. He is also recipient of the American Association of Pharmaceutical Scientists (AAPS) Graduate Student Research Award in Biotechnology, and American Association of Indian Pharmaceutical Scientists (AAiPS) Graduate Student Research Award 2016.

Pharmacy and Pharmaceutical Sciences

EDUCATION 2009 - 2016 PhD. (Pharmaceutical Sciences and Chemistry) - May 2016 Advisor: Dr. Chi H Lee School of Pharmacy, University of Missouri- Kansas City, Kansas City (MO), USA.

2005 - 2008 Master of Pharmacy (Pharmaceutical Biotechnology) – March 2008. Advisor: Dr. V.K. Dixit Department of Pharmaceutical Sciences, Dr. Hari Singh Gour University, Sagar (MP), India.

2001 - 2004 Bachelor in Pharmacy- December 2004. Department of Pharmacy, Shri G. S. Institute of Science and Technology Indore (MP), India.

1999 - 2001 Diploma in Pharmacy July 2001. Department of Pharmacy, Government Kalaniketan Polytechnic, Jabalpur (MP), India

Pharmaceutical Sciences and Chemistry

 Dr. Abubakr M. Idris is associate professor of analytical chemistry. He is currently at the Department of Chemistry, College of Science, King Khalid University, Abha, Saudi Arabia. He received his BSc (1994), MSc (1999) and PhD (2005) from the University of Khartoum, Khartoum, Sudan. Idris has authored and coauthored more than eighty papers published in international refereed journals and conferences with an H-Index 15. His research focuses on developing microfluidic analytical technologies and methodologies as well as environmental analysis issues. Idris is currently the Editor-In Chief of Development in Analytical Chemistry. He joins the Editorial Boards of some other journals in analytical, environmental and pharmaceutical chemistry. Idris is also expert in academic development, accreditation and quality issues in higher education.

Research interest

1. Developing microfluidic analytical techniques for fully-automated on-line procedures involving sample treatment, developing reactions and detection.

2. Developing and validating analytical methodologies for various purposes.

3. Optimizing analytical methods by chemometrics and kinetics.

4. Monitoring and assessing chemicals in the environment.

Dr Rohit Mathur has received his PhD in Biomedical Sciences at University of Delhi, INDIA. Currently, he is working as a Faculty (Instructor) in University of Texas M.D. Anderson Cancer Center. His research has focus on chemoresistance mechanisms and improvement of anti-cancer therapies. Currently he is working on Non-Hodgkin’s lymphomas and Myeloma. Based on his research and fellowship training he has received several awards and honors such as Kimberly award for leukemia research. He is serving as an editorial board member of several reputed journals like Journal of leukemia and Kenkyu Journal of Cancers & Advanced Therapies & expert reviewers for journals like Cancer Letters, Journal of Experimental & Clinical Cancer Research, etc. He has authored more than 20 research articles/book chapters. He is a member of American Association of Cancer Research, Indian Cell Biology Society and American Society of Clinical Oncology.

Leukemia, Lymphoma, Myeloma, Epigenetics, Progenitor cells, Non-coding RNA, Chemoresistance, Radiation resistance, DNA damage response, Apoptosis, and Cell cycle regulation

Education: B. Pharm., 1996, Pharm. Sciences, Assiut University, Assiut, Egypt "Very good with honor"

M. Pharm., 2000, Phytochemistry, Assiut University, Assiut, Egypt. Ph. D., 2005, Marine Natural Products Chemistry, Institute for Pharmaceutical Biology, Heinrich-Heine University, Düsseldorf, Germany "Excellent" Positions: 11/1996-06/2000 Teaching Assistant, Faculty of Pharmacy, Assiut University, Assiut, Egypt. 06/2000-01/2002 Associate lecturer, Faculty of Pharmacy, Assiut University, Assiut,

Egypt. 01/2002-07/2005 Research Assistant, Pharmazeutische Biologie Institut der Universität Heinrich- Heine, Düsseldorf, Germany. 09/2005-2010 Lecturer, Department of Pharmacognosy, Faculty of Pharmacy,

Assiut University, Assiut, Egypt. 2010-till now Associate Professor, Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut, Egypt.

2010-till now Associate Professor, Department of Pharmacognosy and Pharmaceutical chemistry

Isolation and identification of bioactive constituents from different natural sources including plants, marine, bacteria, and fungi.

Different chromatographic techniques such as TLC, CC, VLC, GC, and HPLC.

Structure elucidation of natural products using different spectroscopic techniques e.g. UV, IR, MS, 1D, and 2D NMR.

Macro- and microscopical characterization of medicinal plants.

Biological evaluation of natural products.

Dr. Abdul Ahad is an Assistant Professor at Department of Pharmaceutics, College of Pharmacy, King Saud University Riyadh, Saudi Arabia. Dr. Ahad did his Master and Doctorate in Pharmaceutical Sciences from Department of Pharmaceutics, Jamia Hamdard, New Delhi, India. He has filled for two patents with Indian patent office. He has published various high quality research and review articles in several peer-reviewed journals of international repute. He is on Editorial Board of several Pharmaceutical journals and reviewer of many peer-reviewed journals of high impact. His current interest lies in Nanotechnology products for transdermal delivery, Nano-vesicular formulations, controlled release formulations, drug delivery specifically for the management of hypertension and inflammation.

Nanotechnology products for transdermal delivery, Nano-vesicular formulations, controlled release formulations, drug delivery specifically for the management of hypertension and inflammation.

Over 9 years experience in pharmacy academia, dispensing, and drug promotion areas,  Capable of working well under pressure and strict deadlines, Team Player, Self motivated, professionally disciplined, and patient/client oriented,  Exceptional problem solving and sound decision making capabilities, Proven ability to motivate, multiple tasks and work with great attention to details Open-minded and fast learner to new technologies and systems ‘Expert Pharmacist’ level professional license awarded in 2015

Writing papers on topic relevant to specialist subject area. This will include journals, books and other material. investigating new areas of research within specialist subject area; identifying research topic; determining appropriate research methodologies for research; adapting research methodologies; applying appropriate research methodologies for research and analysing results/conclusions to formulate new concepts and ideas; Writing reports to relevant bodies about progress of research. Student mentoring

Prof. Dr. Yusuf TUTAR is the Head of Biochemistry Division and Basic Pharmaceutical Science Department at Faculty of Pharmacy, Cumhuriyet University, Sivas Turkey. Dr. Tutar is also the Head of Biomedical Engineering Program at the same university. He obtained his MSc and PhD at Oregon State University and Texas Tech University respectively. He pursued his postdoctoral study at National Institutes of Health (NIH/NIDDK), USA. His research focuses on Biochemistry, Biophysics, Genetics and Molecular Biology with specialization in the fields of protein structure-function, protein folding, prion, microrna, pseudogenes, molecular cancer, proteomics, genomics, protein expression and characterization by spectroscopic and calorimetric methods.

His research focuses on Biochemistry, Biophysics, Genetics and Molecular Biology with specialization in the fields of protein structure-function, protein folding, prion, microrna, pseudogenes, molecular cancer, proteomics, genomics, protein expression and characterization by spectroscopic and calorimetric methods.

Dr. K. B. KOTESHWARA Associate professor Manipal University Manipal College of Pharmaceutical Sciences India, continuing research in the specialized scientific area of Possess research experience while doing M.Pharm at Dept. of Pharmaceutics, MCOPS, Manipal. Dissertation work entitled “Design and evaluation of Captopril transdermal preparations” under the guidance of Dr. N. Udupa. b) Possess five year research experience while doing Ph.D. at department of Studies in Industrial Chemistry, Kuvempu University, Shankaraghatta, Shimoga. Work entitled “Studies on some novel polymers for pharmaceutical applications” under the guidance of Dr. Vasantakumar Pai. c) Worked and Guided for PG students for their Research work on (24 projects completed as on April 2015). Dr. Dr. K. B. KOTESHWARA is serving as an honorary reviewer for journal of pharmacy & pharmaceutical sciences & other reputed journals.

Possess research experience while doing M.Pharm at Dept. of Pharmaceutics, MCOPS, Manipal.

Dissertation work entitled “Design and evaluation of Captopril transdermal preparations” under the guidance of Dr. N. Udupa.

b) Possess five year research experience while doing Ph.D. at department of Studies in Industrial Chemistry, Kuvempu University, Shankaraghatta, Shimoga.

Work entitled “Studies on some novel polymers for pharmaceutical applications” under the guidance of Dr. Vasantakumar Pai. c) Worked and Guided for PG students for their Research work on (24 projects completed as on April 2015)

Dr. Devdutt Chaturvedi obtained his Ph. D. degree in Medicinal Chemistry, from the Medicinal Chemistry Division of the Central Drug Research Institute (CSIR), Lucknow, India. Thereafter, He worked as a Postdoctoral Fellow (2003-2005) at the University of Georgia, USA. Later on, he has also worked as a Postdoctoral Fellow (2005-2006) at the Institute of Organic Chemistry, University of Goettingen, Germany. He returned to India and worked shortly as a Senior Postdoctoral Fellow (2006-2007) at the Department of Chemistry, Indian Institute of Technology (I. I. T.), Madras and as a Scientist (2007-2011) at the Bioorganic Chemistry Division, Indian Institute of Integrative Medicine (CSIR), Jammu and Natural Products Chemistry Division, North- East Institute of Science and Technology (CSIR), Jorhat-785006, Assam. He has worked on several areas of organic synthesis and medicinal chemistry such as design and synthesis of novel classes of antidiabetic, antifertility, antitubercular, anti-inflammatory, hypolipedemic, anti-HIV/HBV, anti-cancer, antimalarial, antimicrobial, anti-alzheimer agents wherein he has investigated various kinds of structurally diverse synthetic/natural molecules such as steroids, terpenoids, nucleosides, structurally diverse heterocycles, carbamates and related compounds. He has published more than 70 research papers (containing more than 700 citations, with h-index = 20) in reputed international journals and filed 11 patents.

 medicinal chemistry, organic chemistry

Educational Qualification: • Ph.D (Pharmaceutical Sciences): Jaipur National University, Jaipur in May 2011. •

M. Pharm. (Pharmaceutical Chemistry): Guru Jambeshwar University, Hisar, Haryana in 2004.

B. Pharm.: Birla Constt. College, H.N.B Garhwal University (Main Campus), Uttarankhand in 2000.

Details of Professional Experience: Presently working as Professor & Dean at Moradabad Educational Trust, Group of Institutions, Faculty of Pharmacy at Moradabad, U.P. since 14th June 2013.

• Total Experience : 11 yrs. plus • Teaching Experience : 09 yrs. plus • Industrial Experience : 02 yrs. plus

My research focuses is drug development of novel anticonvulsant and antitubercular agents. I am also preparing new analogues in an effort to develop more potent derivatives with improved pharmacokinetic properties. Work is also been done to investigate the possible mechanism(s) of action of these compounds. The research efforts combine synthetic medicinal chemistry with computational study.

ACADEMIC EXPERIENCE (11.5 Years)

Ex-Lecturer, I.G.I.P.S., Nayapalli, B.B.S.R, from dt. 10.12.2003 to dt. 30.06.2004.

Ex-Lecturer, School of Pharmaceutical Sciences, ITER, from 05.07.2004 to 27.08.2008.

Ex-Asst. Prof., School of Pharmaceutical Sciences, SOA Deemed University, from 28.08.2008 to 30.08.2011.

Currently working as an Assoc. Prof., School of Pharmaceutical Sciences, SOA Deemed University, from 01.09.2011 to till date (Continuing). PROFESSIONAL EXPERIENCE (1 yr)  One year experience in Production in Chilika Pharmaceutical Laboratories, Bhubaneswar, Odisha, India. OTHER RESEARCH SKILLS 

Efficiently Handled Radio-active Isotopes using Gamma Counter and Technetium counter. Having a sound knowledge in handling HPLC, Malvern particle size analyzer, Malvern Zeta-sizer, Lyophilizer, Olympus microscope, Inverted microscope, UV-Visible spectrophotometer, Homogenizer, Probe Sonicator, Spray Dryer etc.

Dr. D.Nagasamy Venkatesh is Assistant Professor at Department of Pharmaceutics, JSS College of Pharmacy, Udhagamandalam. India. Dr. D.Nagasamy Venkatesh is interested in developing certain nanobased drug delivery systems for antiviral and anticancer drugs. His research is also involved in developing sustained/controlled drug delivery systems for certain drugs and analytical and bio-analytical method development for drugs. He serves as a reviewer of more than 25 peer reviewed journals including AAPS, Carbohydrate polymer, Indian Journal of Pharmaceutical Sciences. He serves editorial board member for more than 20 international journals. Dr. D.Nagasamy Venkatesh has authored more than 50 peer-reviewed publications. He has received two awards for his presentations/publications in a national level seminar.

Formulation and development of oral sustained release dosage forms.

Dissolution enhancement of poorly soluble drugs by solid dispersion techniques.

Development and evaluation of nanoparticulate drug delivery systems.

Dr.Renu chadha  is currently working at punjab university. Her research interest includes pharmaceutical chemistry, pharmaceutical analysis. she is serving as an honorary editor for Journal of pharmacy & pharmaceutical sciences

Research Field: Polymorphs/solvatomorphs, cocrystals, compatibility studies, Nanoparticles, Inclusion complexes.

Present Research : The emphasis of my present research is to modify the existing therapeutically useful molecules for better solubility and bioavailability. 1. By preparing better polymorphic modifications 2. By preparing co-crystals 3. Encapsulation of the drug molecules in Cyclodextrin cavity 4. In-vitro compatibility 5. Application of, X-Ray Diffraction, thermoanalytical, And Spectroscopic methods for characterization of APIs, cocrystals and polymorphs.

Pharmaceutical Chemistry, Pharmaceutical Analysis

Academic Qualification:

Ph.D - 2012- Rajiv Gandhi University of Health Sciences, Karnataka, Bangalore (Al- Ameen College of Pharmacy, Bangalore).

M.Pharm- 1997- Bangalore University, Bangalore (Government College of Pharmacy, Bangalore).

B.Pharm- 1994- Gulbarga University, Gulbarga. D.Pharm- 1988- Board of Examining Authority, Drugs Control Department, Bangalore.

Methods to increase bioavailability of Class II and Class III BCS drugs including Nanoparticles, microparticles and liposomes; Chronotherapeutic and site-specific delivery for optimization of drug therapy and Pulmonary delivery for optimization of antitubercular therapy.

Dr.mohd. Rajeeb is currently working at punjab university. His research interest includes pharmaceutical chemistry, pharmaceutical analysis. He is serving as an honorary editor for Journal of pharmacy & pharmaceutical sciences.

Assistant Professor Department of Pharmacognosy, Smt. S.S. Patil College of Pharmacy, Chopda

 pharmacology, pharmaceutics

MBA in Healthcare Management, Goldey-Beacom College, Wilmington, DE (Aug 2015- present)

Ph.D. in Pharmaceutics, St. John’s University, NY (Jan 2009- Dec 2013)

M.S. in Industrial Pharmacy, St. John’s University, NY; Dec 2008

B. Pharm., L.M. College of Pharmacy, India; Apr 2006

Pharmacy & Pharmaceutical Sciences

Doctor of Philosophy (Ph.D) - Full Time, specialized in Clinical Pharmacy, Department of Pharmacy Practice, S.R.M. College of Pharmacy, S.R.M University, Kattankulathur, 603 203. (Degree awarded in 2015).

Master of Pharmacy (M.Pharm), specialized in Pharmacology, from J.S.S. College of Pharmacy, Ooty under The Tamilnadu Dr. M.G.R Medical University, Chennai, during 2007-2009. (Distinction - Gold Medal).

Bachelor of Pharmacy (B.Pharm) from S.R.M. College of Pharmacy, Kattankulathur, under The Tamilnadu Dr. M.G.R Medical University, Chennai, during 2003-2006. (Distinction).

Principal Investigator in the study entitled, “Assessment of various second-line treatment regimens on mild to moderate persistent asthmatic patients”.

Co-investigator in the study entitled, “Study on bio enhancer in the treatment of tuberculosis with Rifampicin : An evidence based update - A Randomized Controlled Trial”.

Co-investigator in the study entitled, “Study on bio enhancer in the treatment of tuberculosis with Rifampicin: An evidence based update - A Randomized Controlled Trial”.

Co-investigator in the study entitled, “Prevalence of MDR TB in Kancheepuram district, Tamilnadu state”.

Co-investigator in the study entitled, “Efficacy of vitamin D3 in severe asthmatic patients”.

Worked as a Research Associate in Formulation Development in Granules India Limited, Hyderabad, India from 12-21-2011 – 07-01-2013.

Worked as a Senior Research Associate in Formulation Development in TherDose Pharma Pvt Ltd, Hyderabad, India from 04-03-2014 – 08-26-2015.

Worked as a Senior Research Fellow in Formulation Development in IriSys LLC, SanDiego (CA), USA from 10-05-2015 to 06-01-2016.

Currently working as a Senior Formulation Scientist in Formulation Development in Sciegen Pharmaceuticals INC, NY, USA from 06-10-2016 to till date.

Formulation Development, solid oral and sterile dosage form development, clinical manufacturing material & technology transfer from R&D to commercial manufacturing

Dr. anil kumar " is currently working at punjab university. His research interest includes Neurodegenerative and Neuropsychiatric disorders: Alzheimer and Huntington’s disease Parkinson diseases, Depression, Epilepsy etc ,Stress, stroke and stress-related pathologies: possible role of antioxidant, flavanoidsNeurobiology of sleep and sleep-related disorders: Possible GABAergic mechanism Diabetes and related complications- neuropathic pain, neuropathy Pain and inflammation. He is serving as an honorary reviewer for Journal of pahrmacy & pharmaceutical sciences

Neurodegenerative and Neuropsychiatric disorders: Alzheimer and Huntington’s disease Parkinson diseases, Depression, Epilepsy etc  Stress, stroke and stress-related pathologies: possible role of antioxidant, flavanoids  Neurobiology of sleep and sleep-related disorders: Possible GABAergic mechanism  Diabetes and related complications- neuropathic pain, neuropathy  Pain and inflammation

Mostafa Heidari Majd. Ph.D of Medicinal Chemistry. Assistance Professor in Faculty of Pharmacy. Zabol University of Medical Science. Zabol, Iran. I am working on Nanomedicine, Drug Delivery, Synthesis of Nano drugs, Drug Complexes, Magnetic Solid Phase Extraction and etc.

Nanomedicine, Drug Delivery, Synthesis of Nano drugs, Drug Complexes, Magnetic Solid Phase Extraction.

Myself Dr.Syed Muzeeb an experienced DMPK and clinical Pharmacology Scientist currently working as post-doctoral Associate with Prof Hartmut Derendorf, Department of Pharmaceutics, University of Florida, United states. To give you a brief back ground of my expertise, I have 16 years of experience in pre-clinical and clinical development of discovery and development of new chemical entities. I have worked in different parts of the world during my scientific carrier. I worked for several years (2001-2009) with Department of drug metabolism and Pharmacokinetics with Dr.Reddy laboratories Ltd , Hyderabad, India (A major drug discovery and development company) involving pre-clinical and clinical development of new molecules of various class of therapeutic like anti-diabetics, anti-cancer, Anti-infectives, Anti-Inflammatory, lipid lowering agents etc. In 2009 I moved to Denmark to pursue my doctoral studies in School of Pharmacy, university of Copenhagen, Denmark. As a part of my doctoral studies I have worked in the area of drug induced liver injury (DILI) caused by reactive drug metabolites. Later I moved to unites states for my post-doctoral studies with Prof Hartmut derendorf, University of florida. Currently I am working on understanding the PK/PD modelling and Pharmacometrics area.

I have 16 years of experience in pre-clinical and clinical development of discovery and development of new chemical entities.

PK/PD modelling and Pharmacometrics area.

Sai Prachetan Balguri obtained his Bachelor’s degree in the Pharmaceutical Sciences from the Kakatiya University, India. He carried out his PhD work in pharmaceutical sciences with emphasis in Pharmaceutics from the University of Mississippi, MS, USA. Currently, he is working as an ORISE research fellow at U.S. FDA in the office of pharmaceutical quality (OPQ). His research encompasses the expertise and experience garnered from academia, industry and agency. Sai worked on several collaborated and individual research projects awarded from National Institutes of Health (NIH) and other agencies. His research expertise is concentrated on the design and development of Novel Drug Delivery Systems for delivering oral, sub-lingual and ocular small molecule therapeutics.

Design and development of Novel Drug Delivery Systems for delivering oral, sub-lingual and ocular small molecule therapeutics.

Design and development of patient- centric pediatric oral formulations.

09/2016- Present, Scientist, Formulation Development, Teva Pharmaceuticals Global Branded R&D, West Chester, PA

08/2015-08/2016, Visiting Scholar, Pre-formulation, Merck & Co., Inc., West Point, PA

06/2014-09/2014, Research Intern, Analytical Science and Pre-formulation, Merck & Co., Inc., West Point, PA

07/2013-06/2014, Global Research Fellow, Small Molecule Group, U.S. Pharmacopeial Convention, Rockville, MD

Dr. Rajesh R Wakaskar has received his Ph.D. in Pharmaceutical Sciences from the University of Nebraska Medical Center in 2015. Currently, he is working as a Formulation Scientist at Insys Therapeutics. His current profile encompasses providing support in Pre-formulation and Formulation Development, Clinical supplies manufacture, API and Drug Product Stability and writing CMC sections of the IND and NDA that are submitted to the FDA for review and approval of pharmaceutical products. His graduate project involved the development of shell cross-linked polymeric micelles (nanocarriers) for the delivery of poorly water soluble anti-cancer agents such as Combretastatin A4 (CA4) to improve the existing solubility, efficacy, bioavailability of this drug, and subsequently, overall therapy of breast cancer. Based on his research, he has been awarded several honors in various podia and poster presentations at various conferences and is an author of high impact research articles in reputed journals. Currently, he’s serving as an expert reviewer for various Journals such as Journal of Drug Delivery, Science and Technology, Clinical Pharmacology & Biopharmaceutics Journal, Cardiovascular Pharmacology, Advances in Pharmacoepidemiology & Drug Safety, Journal of Applied Pharmacy, Pharmaceutical Sciences, Journal of Molecular Biomarkers and Diagnosis (to name a few).

Developing and improving upon the existing concepts of drug delivery. Providing specific insights into the development of nanotechnology, both as a therapeutic and diagnostic tool. Aiding the successful transition of bench-scale science to clinical development of therapeutic products.

Takashiro AKITSU, PhD is a full Professor for the Department of Chemistry, Faculty of Science Division II at Tokyo University of Science. He completed his under graduate school training (chemistry) from Osaka University, Japan and his graduate school training (physical & inorganic chemistry, especially coordination, crystal and bioinorganic chemistry) from Osaka University, Japan. Dr. Akitsu has published up to about 150 articles in peer-reviewed journals and has had posters presented at international level. He has been a peer reviewer of many journals and acted an organizing committee of several international conferences.

Absorption of light by chiral metal complexes and their hybrid materials